Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bidirectional, Multicenter Cohort Study of Inflammatory Bowel Disease (IBD) Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

NCT06939569 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT06939569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06939569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bidirectional, Multicenter Cohort Study of Inflammatory Bowel Disease (IBD) Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
Lead sponsor
Shanghai East Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 1, 2027
Enrollment
337 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease (ibd), metabolic dysfunction associated fatty liver disease